TIAA CREF Investment Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $5.49M | Buy |
141,641
+13,024
| +10% | +$505K | ﹤0.01% | 1379 |
|
|
2018
Q4 | $2.62M | Sell |
128,617
-36,019
| -22% | -$733K | ﹤0.01% | 1800 |
|
|
2018
Q3 | $7.55M | Buy |
164,636
+99,878
| +154% | +$4.58M | ﹤0.01% | 1289 |
|
|
2018
Q2 | $3.83M | Sell |
64,758
-5,293
| -8% | -$313K | ﹤0.01% | 1791 |
|
|
2018
Q1 | $4.77M | Sell |
70,051
-47,020
| -40% | -$3.2M | ﹤0.01% | 1579 |
|
|
2017
Q4 | $11.6M | Sell |
117,071
-12,735
| -10% | -$1.26M | 0.01% | 1052 |
|
|
2017
Q3 | $15.5M | Buy |
129,806
+6,692
| +5% | +$801K | 0.01% | 885 |
|
|
2017
Q2 | $10.8M | Buy |
123,114
+27,230
| +28% | +$2.38M | 0.01% | 1081 |
|
|
2017
Q1 | $3.57M | Sell |
95,884
-14,113
| -13% | -$525K | ﹤0.01% | 1793 |
|
|
2016
Q4 | $3.38M | Buy |
109,997
+26,445
| +32% | +$812K | ﹤0.01% | 1883 |
|
|
2016
Q3 | $5.6K | Buy |
83,552
+4,321
| +5% | +$290 | ﹤0.01% | 1532 |
|
|
2016
Q2 | $2.36M | Buy |
79,231
+5,423
| +7% | +$162K | ﹤0.01% | 2014 |
|
|
2016
Q1 | $2.17M | Buy |
73,808
+609
| +0.8% | +$17.9K | ﹤0.01% | 2021 |
|
|
2015
Q4 | $5.74M | Sell |
73,199
-8,102
| -10% | -$635K | ﹤0.01% | 1470 |
|
|
2015
Q3 | $6.13M | Sell |
81,301
-10,542
| -11% | -$794K | ﹤0.01% | 1399 |
|
|
2015
Q2 | $10.7M | Sell |
91,843
-13,343
| -13% | -$1.56M | 0.01% | 1105 |
|
|
2015
Q1 | $24.8M | Buy |
105,186
+923
| +0.9% | +$218K | 0.02% | 706 |
|
|
2014
Q4 | $19.7M | Sell |
104,263
-4,381
| -4% | -$829K | 0.01% | 779 |
|
|
2014
Q3 | $25.9M | Sell |
108,644
-2,594
| -2% | -$619K | 0.02% | 679 |
|
|
2014
Q2 | $7.34M | Buy |
111,238
+2,153
| +2% | +$142K | 0.01% | 1394 |
|
|
2014
Q1 | $11.4M | Sell |
109,085
-2,229
| -2% | -$232K | 0.01% | 1058 |
|
|
2013
Q4 | $11.5M | Sell |
111,314
-452
| -0.4% | -$46.8K | 0.01% | 1066 |
|
|
2013
Q3 | $6M | Sell |
111,766
-530
| -0.5% | -$28.4K | ﹤0.01% | 1448 |
|
|
2013
Q2 | $4.98M | Buy |
+112,296
| New | +$4.98M | ﹤0.01% | 1523 |
|